MORGAN STANLEY PLC/CALL/INTUITIVE SURGICAL/560/0.01/20.12.24 Stock

Warrant

DE000MB8B3M7

Real-time Bid/Ask 09:15:39 2024-05-23 am EDT
0.049 EUR / 0.064 EUR +9.62% Intraday chart for MORGAN STANLEY PLC/CALL/INTUITIVE SURGICAL/560/0.01/20.12.24
Current month+44.44%
1 month+36.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 0.049 -5.77%
24-05-22 0.052 +4.00%
24-05-21 0.05 -5.66%
24-05-20 0.053 +3.92%
24-05-17 0.051 -3.77%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 08:34 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
Issuer Morgan Stanley
WKN MB8B3M
ISINDE000MB8B3M7
Date issued 2023-07-04
Strike 560 $
Maturity 2024-12-20 (211 Days)
Parity 100 : 1
Emission price 0.11
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.155
Lowest since issue 0.033
Spread 0.01
Spread %16.39%

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
400.9 USD
Average target price
420.4 USD
Spread / Average Target
+4.86%
Consensus